My Quote Request
6505-01-126-7701
20 Products
NILSTAT
NYSTATIN VAGINAL TABLETS,USP
NSN, MFG P/N
6505011267701
NSN
6505-01-126-7701
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100000.000 UNITS NYSTATIN ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 TABLETS
PRIMARY CONTAINER TYPE: PACKAGE
SPECIAL FEATURES: WITH APPLICATOR
Related Searches:
CAPOTEN
CAPTOPRIL TABLETS,USP
NSN, MFG P/N
6505011269194
NSN
6505-01-126-9194
MFG
SQUIBB E R AND SONS INC WORLD HQ
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS CAPTOPRIL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CAPTOPRIL TABLETS USP 100MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
CAPOTEN TABLETS
CAPTOPRIL TABLETS,USP
NSN, MFG P/N
6505011269194
NSN
6505-01-126-9194
CAPOTEN TABLETS
CAPTOPRIL TABLETS,USP
NSN, MFG P/N
6505011269194
NSN
6505-01-126-9194
MFG
SQUIBB E R AND SONS INC WORLD HQ
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS CAPTOPRIL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CAPTOPRIL TABLETS USP 100MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00003-0485-50
CAPTOPRIL TABLETS,USP
NSN, MFG P/N
6505011269194
NSN
6505-01-126-9194
NDC00003-0485-50
CAPTOPRIL TABLETS,USP
NSN, MFG P/N
6505011269194
NSN
6505-01-126-9194
MFG
PAR PHARMACEUTICAL INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS CAPTOPRIL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CAPTOPRIL TABLETS USP 100MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC59772-7048-01
CAPTOPRIL TABLETS,USP
NSN, MFG P/N
6505011269194
NSN
6505-01-126-9194
NDC59772-7048-01
CAPTOPRIL TABLETS,USP
NSN, MFG P/N
6505011269194
NSN
6505-01-126-9194
MFG
SANDOZ CONSUMER HEALTH CARE GROUP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS CAPTOPRIL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CAPTOPRIL TABLETS USP 100MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00002-1094-02
METHIMAZOLE TABLETS,USP
NSN, MFG P/N
6505011269270
NSN
6505-01-126-9270
NDC00002-1094-02
METHIMAZOLE TABLETS,USP
NSN, MFG P/N
6505011269270
NSN
6505-01-126-9270
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS METHIMAZOLE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHIMAZOLE TABLETS USP 5MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC52604-1094-01
METHIMAZOLE TABLETS,USP
NSN, MFG P/N
6505011269270
NSN
6505-01-126-9270
NDC52604-1094-01
METHIMAZOLE TABLETS,USP
NSN, MFG P/N
6505011269270
NSN
6505-01-126-9270
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS METHIMAZOLE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHIMAZOLE TABLETS USP 5MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
TAPAZOLE
METHIMAZOLE TABLETS,USP
NSN, MFG P/N
6505011269270
NSN
6505-01-126-9270
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS METHIMAZOLE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHIMAZOLE TABLETS USP 5MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
TAPAZOLE TABLETS
METHIMAZOLE TABLETS,USP
NSN, MFG P/N
6505011269270
NSN
6505-01-126-9270
TAPAZOLE TABLETS
METHIMAZOLE TABLETS,USP
NSN, MFG P/N
6505011269270
NSN
6505-01-126-9270
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS METHIMAZOLE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHIMAZOLE TABLETS USP 5MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00005-2084-08
POLIOVIRUS VACCINE LIVE ORAL,USP
NSN, MFG P/N
6505011270046
NSN
6505-01-127-0046
NDC00005-2084-08
POLIOVIRUS VACCINE LIVE ORAL,USP
NSN, MFG P/N
6505011270046
NSN
6505-01-127-0046
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
III EXTERIOR CONTAINER WEIGHT: 29.00 POUNDS
III SUPPLEMENTARY FEATURES: NOTE: W
III UNIT OF ISSUE CUBE: 0.004 CUBIC FEET
IMMEDIATE CONTAINER QUANTITY: 10
IMMEDIATE CONTAINER TYPE: PIPETTE,SINGLE-DOSE
QUANTITY WITHIN EACH IMMEDIATE CONTAINER: 1 DOSE
UNIT PACKAGE QUANTITY: 10
UNIT PACKAGE TYPE: PACKAGE
Related Searches:
NDC00536-1359-12
GLYCERIN SUPPOSITORIES,USP
NSN, MFG P/N
6505011272214
NSN
6505-01-127-2214
NDC00536-1359-12
GLYCERIN SUPPOSITORIES,USP
NSN, MFG P/N
6505011272214
NSN
6505-01-127-2214
MFG
RUGBY GROUP INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GLYCERIN SUPPOSITORIES USP ADULT RECTAL 12 SUPPOSITORIES/JAR
PRIMARY CONTAINER TYPE: JAR
SUPPOSITORY TYPE: ADULT RECTAL
UNIT PACKAGE QUANTITY: 12 SUPPOSITORIES PER PACKAGE
Related Searches:
NDC00713-0102-13
GLYCERIN SUPPOSITORIES,USP
NSN, MFG P/N
6505011272214
NSN
6505-01-127-2214
NDC00713-0102-13
GLYCERIN SUPPOSITORIES,USP
NSN, MFG P/N
6505011272214
NSN
6505-01-127-2214
MFG
G & W LABORATORIES INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GLYCERIN SUPPOSITORIES USP ADULT RECTAL 12 SUPPOSITORIES/JAR
PRIMARY CONTAINER TYPE: JAR
SUPPOSITORY TYPE: ADULT RECTAL
UNIT PACKAGE QUANTITY: 12 SUPPOSITORIES PER PACKAGE
Related Searches:
NDC00904-2667-12
GLYCERIN SUPPOSITORIES,USP
NSN, MFG P/N
6505011272214
NSN
6505-01-127-2214
NDC00904-2667-12
GLYCERIN SUPPOSITORIES,USP
NSN, MFG P/N
6505011272214
NSN
6505-01-127-2214
MFG
MAJOR PHARMACEUTICALS INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GLYCERIN SUPPOSITORIES USP ADULT RECTAL 12 SUPPOSITORIES/JAR
PRIMARY CONTAINER TYPE: JAR
SUPPOSITORY TYPE: ADULT RECTAL
UNIT PACKAGE QUANTITY: 12 SUPPOSITORIES PER PACKAGE
Related Searches:
NDC45802-0715-30
GLYCERIN SUPPOSITORIES,USP
NSN, MFG P/N
6505011272214
NSN
6505-01-127-2214
NDC45802-0715-30
GLYCERIN SUPPOSITORIES,USP
NSN, MFG P/N
6505011272214
NSN
6505-01-127-2214
MFG
CLAY-PARK LABORATORIES INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GLYCERIN SUPPOSITORIES USP ADULT RECTAL 12 SUPPOSITORIES/JAR
PRIMARY CONTAINER TYPE: JAR
SUPPOSITORY TYPE: ADULT RECTAL
UNIT PACKAGE QUANTITY: 12 SUPPOSITORIES PER PACKAGE
Related Searches:
NDC54092-0501-12
GLYCERIN SUPPOSITORIES,USP
NSN, MFG P/N
6505011272214
NSN
6505-01-127-2214
NDC54092-0501-12
GLYCERIN SUPPOSITORIES,USP
NSN, MFG P/N
6505011272214
NSN
6505-01-127-2214
MFG
ROBERTS PHARMACEUTICAL CORP
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GLYCERIN SUPPOSITORIES USP ADULT RECTAL 12 SUPPOSITORIES/JAR
PRIMARY CONTAINER TYPE: JAR
SUPPOSITORY TYPE: ADULT RECTAL
UNIT PACKAGE QUANTITY: 12 SUPPOSITORIES PER PACKAGE
Related Searches:
2B1654
DEXTROSE,POTASSIUM CHLORIDE,AND SODIUM CHLORIDE INJECTION
NSN, MFG P/N
6505011274005
NSN
6505-01-127-4005
2B1654
DEXTROSE,POTASSIUM CHLORIDE,AND SODIUM CHLORIDE INJECTION
NSN, MFG P/N
6505011274005
NSN
6505-01-127-4005
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 0.150 PERCENTAGE, W/V POTASSIUM CHLORIDE ACTIVE INGREDIENT AND 0.450 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROSE POTASSIUM CHLORIDE & SODIUM CHLORIDE INJ 1000ML BAG 14S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: TRANSPARENT FLEXIBLE PLASTIC BAG HAVING TWO PERMANENTLY ATTACHED OUTLETPORTS
TOTAL PRIMARY CONTAINER QUANTITY: 14
Related Searches:
NDC00338-0671-04
DEXTROSE,POTASSIUM CHLORIDE,AND SODIUM CHLORIDE INJECTION
NSN, MFG P/N
6505011274005
NSN
6505-01-127-4005
NDC00338-0671-04
DEXTROSE,POTASSIUM CHLORIDE,AND SODIUM CHLORIDE INJECTION
NSN, MFG P/N
6505011274005
NSN
6505-01-127-4005
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 0.150 PERCENTAGE, W/V POTASSIUM CHLORIDE ACTIVE INGREDIENT AND 0.450 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROSE POTASSIUM CHLORIDE & SODIUM CHLORIDE INJ 1000ML BAG 14S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: TRANSPARENT FLEXIBLE PLASTIC BAG HAVING TWO PERMANENTLY ATTACHED OUTLETPORTS
TOTAL PRIMARY CONTAINER QUANTITY: 14
Related Searches:
NDC00338-0673-04
DEXTROSE,POTASSIUM CHLORIDE,AND SODIUM CHLORIDE INJECTION
NSN, MFG P/N
6505011274007
NSN
6505-01-127-4007
NDC00338-0673-04
DEXTROSE,POTASSIUM CHLORIDE,AND SODIUM CHLORIDE INJECTION
NSN, MFG P/N
6505011274007
NSN
6505-01-127-4007
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 0.224 PERCENTAGE, W/V POTASSIUM CHLORIDE ACTIVE INGREDIENT AND 0.450 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INSULIN INJECTION USP 100UN/ML PORK PANCREAS 10ML VIAL 14S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: TRANSPARENT FLEXIBLE PLASTIC BAG HAVING TWO PERMANENTLY ATTACHED OUTLET PORTS
TOTAL PRIMARY CONTAINER QUANTITY: 14
Related Searches:
NDC00338-0675-04
DEXTROSE,POTASSIUM CHLORIDE,AND SODIUM CHLORIDE INJECTION
NSN, MFG P/N
6505011274008
NSN
6505-01-127-4008
NDC00338-0675-04
DEXTROSE,POTASSIUM CHLORIDE,AND SODIUM CHLORIDE INJECTION
NSN, MFG P/N
6505011274008
NSN
6505-01-127-4008
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 0.300 PERCENTAGE, W/V POTASSIUM CHLORIDE ACTIVE INGREDIENT AND 0.450 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROSE POTASSIUM CHLORIDE AND SODIUM CHLORIDE INJ 1000ML BAG 14S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: TRANSPARENT FLEXIBLE PLASTIC BAG HAVING TWO PERMANENTLY ATTACHED OUTLETPORTS
TOTAL PRIMARY CONTAINER QUANTITY: 14
Related Searches:
NDC00086-0049-05
MEDROXYPROGESTERONE ACETATE TABLETS,USP
NSN, MFG P/N
6505011274046
NSN
6505-01-127-4046
NDC00086-0049-05
MEDROXYPROGESTERONE ACETATE TABLETS,USP
NSN, MFG P/N
6505011274046
NSN
6505-01-127-4046
MFG
CARNRICK G W CO CARNRICK LABORATORIES INC DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS MEDROXYPROGESTERONE ACETATE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE